News|Articles|June 16, 2026

Industry Roundup: A New Generation of Laboratory Balance from Sartorius

Author(s)LCGC Staff
Listen
0:00 / 0:00

Key Takeaways

  • Direct, built-in connectivity eliminates middleware, simplifying integration with data-management ecosystems and lowering total cost of ownership while supporting modern multi-site, digital laboratory workflows.
  • Two configurations address divergent operating contexts: the standard model emphasizes guided workflows and documentation, whereas Cubis III Max adds audit trails and 21 CFR Part 11-oriented capabilities.
SHOW MORE

For scientists who depend on accurate, traceable data every day, the tools they use matter enormously. Sartorius, a global leader in biopharma research and manufacturing solutions, has introduced its latest generation of laboratory balance—the Cubis III—and it reflects how much the expectations placed on such instruments have changed in recent years.

For scientists who depend on accurate, traceable data every day, the tools they use matter enormously. Sartorius, a global leader in biopharma research and manufacturing solutions, has introduced its latest generation of laboratory balance—the Cubis III—and it reflects how much the expectations placed on such instruments have changed in recent years.

More Than a Balance

Precision has always been the baseline requirement for any laboratory balance. What has changed is everything around it. Modern laboratories increasingly operate within complex digital environments, connecting instruments to data management systems, navigating regulatory requirements, and managing data integrity across multiple sites and workflows. The Cubis III is Sartorius's answer to that shift—a balance designed not just to weigh accurately, but to fit into the way contemporary laboratories work.

A notable aspect of the design is the elimination of middleware, the additional software layer that has traditionally been required to connect balances to laboratory information systems. With Cubis III, that connection is built in, which Sartorius says reduces both cost and complexity over the lifetime of the instrument.1

Two Options, One Standard of Performance

The portfolio comes in two versions. The standard Cubis III is aimed at laboratories that want reliable, high-quality weighing with straightforward digital documentation, but without the overhead of formal compliance requirements. It includes user management, guided workflows, and flexible connectivity options—practical features for busy labs that want things to work simply and reliably.

The Cubis III Max is designed for more tightly regulated settings, such as pharmaceutical or medical device manufacturing, where data integrity requirements are stringent and audit trails are essential. It incorporates features supporting 21 CFR Part 11 compliance and connects directly to several enterprise systems without additional software. Importantly, labs can start with the standard model and upgrade to the Max configuration as their needs develop, which offers some practical flexibility in how facilities plan their investments.1

A Consistent Experience

One detail worth noting is that both models share the same touchscreen interface. For laboratories managing multiple instruments across teams or sites, a consistent user experience simplifies training and helps keep procedures standardized. In settings where human error and procedural consistency matter, such details can make a meaningful difference.

Broad Applicability

While the Cubis III has clear relevance for pharmaceutical and biotech settings, Sartorius positions it across a wider range of applications—from medical device quality control and infusion pump testing to chemical analysis and sample preparation work requiring very small quantities. The availability of ultra-micro configurations extends its usefulness into applications where even tiny variations in sample mass are significant.

About Sartorius

Sartorius is headquartered in Göttingen, Germany, and operates more than 60 production and sales sites worldwide. The company employs over 14,000 people from more than 110 nations and reported revenue of approximately 3.5 billion euros in 2025. Its work spans laboratory instruments and consumables for research and quality control, as well as bioprocess technologies supporting the manufacture of biologics, vaccines, and cell and gene therapies. The Cubis III sits within the laboratory instruments side of that portfolio, aimed at scientists and quality professionals across both regulated and non-regulated environments.2

References

  1. New Cubis® III – Made to Connect to Your Lab. Sartorius website. https://www.sartorius.com/en (accessed 2026-06-15)
  2. Sartorius. LinkedIn website. https://www.linkedin.com/company/sartorius/ (accessed 2026-06-15)